> top > docs > PMC:3218875 > spans > 3099-3643 > annotations

PMC:3218875 / 3099-3643 JSONTXT

Annnotations TAB JSON ListView MergeView

testone

Id Subject Object Predicate Lexical cue
T1642 351-354 Protein denotes TNF
T1641 276-279 Protein denotes TNF
T1640 217-220 Protein denotes TNF

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T2709 543-544 . denotes .
T2708 542-543 -RRB- denotes )
T2707 541-542 NNP denotes ]
T2706 540-541 CD denotes 3
T2705 539-540 NNP denotes [
T2704 536-538 IN denotes in
T2703 527-535 VBN denotes reviewed
T2702 526-527 -LRB- denotes (
T2701 523-525 NNP denotes RA
T2700 520-522 IN denotes in
T2699 509-519 NNS denotes activities
T2698 492-508 JJ denotes pro-inflammatory
T2697 486-491 PRP$ denotes their
T2696 483-485 IN denotes of
T2695 478-482 JJS denotes most
T2694 469-477 VBZ denotes mediates
T2693 459-468 NNS denotes cytokines
T2692 453-458 DT denotes these
T2691 450-452 IN denotes by
T2690 439-449 NN denotes activation
T2689 433-438 JJ denotes NF-κB
T2688 428-432 DT denotes that
T2687 419-427 VBN denotes expected
T2686 416-418 VB denotes be
T2685 412-415 MD denotes can
T2684 409-411 PRP denotes it
T2683 405-408 CC denotes and
T2682 399-404 NN denotes NF-κB
T2681 396-398 IN denotes of
T2680 385-395 NNS denotes activators
T2679 378-384 JJ denotes potent
T2678 373-377 RB denotes very
T2677 368-372 DT denotes both
T2633 151-153 IN denotes in
T2632 145-150 NN denotes NF-κB
T2631 136-144 VBP denotes activate
T2630 131-135 IN denotes that
T2629 122-130 VBZ denotes triggers
T2628 112-121 JJ denotes molecular
T2627 108-111 DT denotes the
T2626 105-107 IN denotes of
T2625 90-104 NN denotes identification
T2624 86-89 DT denotes the
T2623 81-85 IN denotes with
T2622 75-80 NNS denotes deals
T2621 66-74 NN denotes research
T2620 61-65 JJ denotes much
T2619 59-60 , denotes ,
T2618 57-59 NNP denotes RA
T2617 54-56 IN denotes in
T2616 41-53 NN denotes inflammation
T2615 38-40 IN denotes of
T2614 30-37 NN denotes process
T2613 26-29 DT denotes the
T2612 23-25 TO denotes to
T2611 15-22 JJ denotes central
T2610 12-14 VBZ denotes is
T2609 6-11 NNP denotes NF-κB
T2608 0-5 IN denotes Since
T2676 364-367 VBP denotes are
T2675 359-363 NNP denotes IL-1
T2674 355-358 CC denotes and
T2673 351-354 NNP denotes TNF
T2672 349-350 . denotes .
T2671 348-349 -RRB- denotes )
T2670 347-348 NNP denotes ]
T2669 346-347 CD denotes 9
T2668 345-346 NNP denotes [
T2667 342-344 IN denotes in
T2666 333-341 VBN denotes reviewed
T2665 332-333 -LRB- denotes (
T2664 329-331 NNP denotes RA
T2663 322-328 JJ denotes severe
T2662 318-321 IN denotes for
T2661 308-317 NN denotes treatment
T2660 298-307 JJ denotes effective
T2659 295-297 DT denotes an
T2658 292-294 VBZ denotes is
T2657 280-291 NNS denotes antagonists
T2656 276-279 NNP denotes TNF
T2655 273-275 IN denotes of
T2654 258-272 NN denotes administration
T2653 254-257 CC denotes and
T2652 252-253 , denotes ,
T2651 248-252 NN denotes role
T2650 238-247 JJ denotes important
T2649 235-237 DT denotes an
T2648 230-234 VBP denotes play
T2647 225-229 NNP denotes IL-1
T2646 221-224 CC denotes and
T2645 217-220 NNP denotes TNF
T2644 214-216 IN denotes as
T2643 209-213 JJ denotes such
T2642 199-208 NNS denotes cytokines
T2641 183-198 JJ denotes proinflammatory
T2640 178-182 IN denotes that
T2639 169-177 VBN denotes accepted
T2638 164-168 RB denotes well
T2637 161-163 VBZ denotes is
T2636 158-160 PRP denotes It
T2635 156-157 . denotes .
T2634 154-156 NNP denotes RA
R1987 T2608 T2610 mark Since,is
R1988 T2609 T2610 nsubj NF-κB,is
R1989 T2610 T2622 advcl is,deals
R1990 T2611 T2610 acomp central,is
R1991 T2612 T2611 prep to,central
R1992 T2613 T2614 det the,process
R1993 T2614 T2612 pobj process,to
R1994 T2615 T2614 prep of,process
R1995 T2616 T2615 pobj inflammation,of
R1996 T2617 T2614 prep in,process
R1997 T2618 T2617 pobj RA,in
R1998 T2619 T2622 punct ",",deals
R1999 T2620 T2622 amod much,deals
R2000 T2621 T2622 compound research,deals
R2001 T2622 T2622 ROOT deals,deals
R2002 T2623 T2622 prep with,deals
R2003 T2624 T2625 det the,identification
R2004 T2625 T2623 pobj identification,with
R2005 T2626 T2625 prep of,identification
R2006 T2627 T2628 det the,molecular
R2007 T2628 T2626 pobj molecular,of
R2008 T2629 T2622 conj triggers,deals
R2009 T2630 T2631 nsubj that,activate
R2010 T2631 T2629 ccomp activate,triggers
R2011 T2632 T2631 dobj NF-κB,activate
R2012 T2633 T2631 prep in,activate
R2013 T2634 T2633 pobj RA,in
R2014 T2635 T2629 punct .,triggers
R2015 T2636 T2639 nsubjpass It,accepted
R2016 T2637 T2639 auxpass is,accepted
R2017 T2638 T2639 advmod well,accepted
R2018 T2639 T2639 ROOT accepted,accepted
R2019 T2640 T2648 mark that,play
R2020 T2641 T2642 amod proinflammatory,cytokines
R2021 T2642 T2648 nsubj cytokines,play
R2022 T2643 T2644 amod such,as
R2023 T2644 T2642 prep as,cytokines
R2024 T2645 T2644 pobj TNF,as
R2025 T2646 T2645 cc and,TNF
R2026 T2647 T2645 conj IL-1,TNF
R2027 T2648 T2639 ccomp play,accepted
R2028 T2649 T2651 det an,role
R2029 T2650 T2651 amod important,role
R2030 T2651 T2648 dobj role,play
R2031 T2652 T2648 punct ",",play
R2032 T2653 T2648 cc and,play
R2033 T2654 T2648 conj administration,play
R2034 T2655 T2654 prep of,administration
R2035 T2656 T2657 compound TNF,antagonists
R2036 T2657 T2655 pobj antagonists,of
R2037 T2658 T2639 conj is,accepted
R2038 T2659 T2661 det an,treatment
R2039 T2660 T2661 amod effective,treatment
R2040 T2661 T2658 attr treatment,is
R2041 T2662 T2661 prep for,treatment
R2042 T2663 T2664 amod severe,RA
R2043 T2664 T2662 pobj RA,for
R2044 T2665 T2666 punct (,reviewed
R2045 T2666 T2664 parataxis reviewed,RA
R2046 T2667 T2666 prep in,reviewed
R2047 T2668 T2667 pobj [,in
R2048 T2669 T2670 nummod 9,]
R2049 T2670 T2668 appos ],[
R2050 T2671 T2668 punct ),[
R2051 T2672 T2639 punct .,accepted
R2052 T2673 T2676 nsubj TNF,are
R2053 T2674 T2673 cc and,TNF
R2054 T2675 T2673 conj IL-1,TNF
R2055 T2676 T2676 ROOT are,are
R2056 T2677 T2676 dep both,are
R2057 T2678 T2679 advmod very,potent
R2058 T2679 T2680 amod potent,activators
R2059 T2680 T2676 attr activators,are
R2060 T2681 T2680 prep of,activators
R2061 T2682 T2681 pobj NF-κB,of
R2062 T2683 T2676 cc and,are
R2063 T2684 T2687 nsubjpass it,expected
R2064 T2685 T2687 aux can,expected
R2065 T2686 T2687 auxpass be,expected
R2066 T2687 T2676 conj expected,are
R2067 T2688 T2690 det that,activation
R2068 T2689 T2690 amod NF-κB,activation
R2069 T2690 T2694 nsubj activation,mediates
R2070 T2691 T2690 prep by,activation
R2071 T2692 T2693 det these,cytokines
R2072 T2693 T2691 pobj cytokines,by
R2073 T2694 T2676 conj mediates,are
R2074 T2695 T2694 dobj most,mediates
R2075 T2696 T2695 prep of,most
R2076 T2697 T2699 poss their,activities
R2077 T2698 T2699 amod pro-inflammatory,activities
R2078 T2699 T2696 pobj activities,of
R2079 T2700 T2699 prep in,activities
R2080 T2701 T2700 pobj RA,in
R2081 T2702 T2701 punct (,RA
R2082 T2703 T2694 advcl reviewed,mediates
R2083 T2704 T2703 prep in,reviewed
R2084 T2705 T2704 pobj [,in
R2085 T2706 T2707 nummod 3,]
R2086 T2707 T2705 appos ],[
R2087 T2708 T2705 punct ),[
R2088 T2709 T2694 punct .,mediates

DLUT931

Id Subject Object Predicate Lexical cue
T3362 351-354 Protein denotes TNF
T3361 276-279 Protein denotes TNF
T3360 217-220 Protein denotes TNF

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T3273 351-354 http://www.uniprot.org/uniprot/P01375 denotes TNF
T3272 276-279 http://www.uniprot.org/uniprot/P01375 denotes TNF
T3271 217-220 http://www.uniprot.org/uniprot/P01375 denotes TNF

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T1819 351-354 Protein denotes TNF
T1818 276-279 Protein denotes TNF
T1817 217-220 Protein denotes TNF

2_test

Id Subject Object Predicate Lexical cue
21639951-19798034-4289433 346-347 19798034 denotes 9
21639951-18982160-4289434 540-541 18982160 denotes 3

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T1945 542-543 -RRB- denotes )
T1944 541-542 -RRB- denotes ]
T1943 540-541 CD denotes 3
T1942 539-540 -LRB- denotes [
T1941 536-538 IN denotes in
T1940 527-535 VB denotes reviewed
T1939 526-527 -LRB- denotes (
T1938 523-525 NN denotes RA
T1937 520-522 IN denotes in
T1936 509-519 NN denotes activities
T1935 492-508 JJ denotes pro-inflammatory
T1934 486-491 PRP-DOLLAR- denotes their
T1933 483-485 IN denotes of
T1932 478-482 JJ denotes most
T1931 469-477 VB denotes mediates
T1930 459-468 NN denotes cytokines
T1929 453-458 DT denotes these
T1928 450-452 IN denotes by
T1927 439-449 NN denotes activation
T1926 433-438 NN denotes NF-κB
T1925 428-432 IN denotes that
T1924 419-427 VB denotes expected
T1923 416-418 VB denotes be
T1922 412-415 MD denotes can
T1921 409-411 PRP denotes it
T1920 405-408 CC denotes and
T1919 399-404 NN denotes NF-κB
T1918 396-398 IN denotes of
T1917 385-395 NN denotes activators
T1916 378-384 JJ denotes potent
T1915 373-377 RB denotes very
T1914 368-372 DT denotes both
T1913 364-367 VB denotes are
T1912 359-363 NN denotes IL-1
T1911 355-358 CC denotes and
T1910 351-354 NN denotes TNF
T1909 348-349 -RRB- denotes )
T1908 347-348 -RRB- denotes ]
T1907 346-347 CD denotes 9
T1906 345-346 -LRB- denotes [
T1905 342-344 IN denotes in
T1904 333-341 VB denotes reviewed
T1903 332-333 -LRB- denotes (
T1902 329-331 NN denotes RA
T1901 322-328 JJ denotes severe
T1900 318-321 IN denotes for
T1899 308-317 NN denotes treatment
T1898 298-307 JJ denotes effective
T1897 295-297 DT denotes an
T1896 292-294 VB denotes is
T1895 280-291 NN denotes antagonists
T1894 276-279 NN denotes TNF
T1893 273-275 IN denotes of
T1892 258-272 NN denotes administration
T1891 254-257 CC denotes and
T1890 252-253 -COMMA- denotes ,
T1889 248-252 NN denotes role
T1888 238-247 JJ denotes important
T1887 235-237 DT denotes an
T1886 230-234 VB denotes play
T1885 225-229 NN denotes IL-1
T1884 221-224 CC denotes and
T1883 217-220 NN denotes TNF
T1882 214-216 IN denotes as
T1881 209-213 JJ denotes such
T1880 199-208 NN denotes cytokines
T1879 183-198 JJ denotes proinflammatory
T1878 178-182 IN denotes that
T1877 169-177 VB denotes accepted
T1876 164-168 RB denotes well
T1875 161-163 VB denotes is
T1874 158-160 PRP denotes It
T1873 154-156 NN denotes RA
T1872 151-153 IN denotes in
T1871 145-150 NN denotes NF-κB
T1870 136-144 VB denotes activate
T1869 131-135 WDT denotes that
T1868 122-130 NN denotes triggers
T1867 112-121 JJ denotes molecular
T1866 108-111 DT denotes the
T1865 105-107 IN denotes of
T1864 90-104 NN denotes identification
T1863 86-89 DT denotes the
T1862 81-85 IN denotes with
T1861 75-80 NN denotes deals
T1860 66-74 NN denotes research
T1859 61-65 JJ denotes much
T1858 59-60 -COMMA- denotes ,
T1857 57-59 NN denotes RA
T1856 54-56 IN denotes in
T1855 41-53 NN denotes inflammation
T1854 38-40 IN denotes of
T1853 30-37 NN denotes process
T1852 26-29 DT denotes the
T1851 23-25 TO denotes to
T1850 15-22 JJ denotes central
T1849 12-14 VB denotes is
T1848 6-11 NN denotes NF-κB
T1847 0-5 IN denotes Since
R1314 T1848 T1849 arg1Of NF-κB,is
R1315 T1848 T1850 arg1Of NF-κB,central
R1316 T1849 T1847 arg2Of is,Since
R1317 T1849 T1862 arg1Of is,with
R1318 T1850 T1849 arg2Of central,is
R1319 T1850 T1851 arg1Of central,to
R1320 T1853 T1851 arg2Of process,to
R1321 T1853 T1852 arg1Of process,the
R1322 T1853 T1854 arg1Of process,of
R1323 T1853 T1856 arg1Of process,in
R1324 T1853 T1858 arg1Of process,","
R1325 T1855 T1854 arg2Of inflammation,of
R1326 T1857 T1856 arg2Of RA,in
R1327 T1861 T1858 arg2Of deals,","
R1328 T1861 T1859 arg1Of deals,much
R1329 T1861 T1860 arg1Of deals,research
R1330 T1864 T1862 arg2Of identification,with
R1331 T1864 T1863 arg1Of identification,the
R1332 T1864 T1865 arg1Of identification,of
R1333 T1868 T1865 arg2Of triggers,of
R1334 T1868 T1866 arg1Of triggers,the
R1335 T1868 T1867 arg1Of triggers,molecular
R1336 T1869 T1870 arg1Of that,activate
R1337 T1870 T1847 arg1Of activate,Since
R1338 T1870 T1872 arg1Of activate,in
R1339 T1871 T1870 arg2Of NF-κB,activate
R1340 T1873 T1872 arg2Of RA,in
R1341 T1874 T1875 arg1Of It,is
R1342 T1874 T1877 arg2Of It,accepted
R1343 T1877 T1875 arg2Of accepted,is
R1344 T1877 T1876 arg1Of accepted,well
R1345 T1880 T1879 arg1Of cytokines,proinflammatory
R1346 T1880 T1882 arg1Of cytokines,as
R1347 T1880 T1886 arg1Of cytokines,play
R1348 T1882 T1881 arg1Of as,such
R1349 T1883 T1884 arg1Of TNF,and
R1350 T1884 T1882 arg2Of and,as
R1351 T1885 T1884 arg2Of IL-1,and
R1352 T1886 T1891 arg1Of play,and
R1353 T1889 T1886 arg2Of role,play
R1354 T1889 T1887 arg1Of role,an
R1355 T1889 T1888 arg1Of role,important
R1356 T1891 T1877 arg3Of and,accepted
R1357 T1891 T1878 arg1Of and,that
R1358 T1891 T1890 arg1Of and,","
R1359 T1892 T1893 arg1Of administration,of
R1360 T1892 T1896 arg1Of administration,is
R1361 T1895 T1893 arg2Of antagonists,of
R1362 T1895 T1894 arg1Of antagonists,TNF
R1363 T1896 T1891 arg2Of is,and
R1364 T1899 T1896 arg2Of treatment,is
R1365 T1899 T1897 arg1Of treatment,an
R1366 T1899 T1898 arg1Of treatment,effective
R1367 T1899 T1900 arg1Of treatment,for
R1368 T1902 T1900 arg2Of RA,for
R1369 T1902 T1901 arg1Of RA,severe
R1370 T1902 T1903 arg1Of RA,(
R1371 T1904 T1903 arg2Of reviewed,(
R1372 T1904 T1905 arg1Of reviewed,in
R1373 T1904 T1906 arg1Of reviewed,[
R1374 T1907 T1906 arg2Of 9,[
R1375 T1908 T1906 arg3Of ],[
R1376 T1909 T1903 arg3Of ),(
R1377 T1910 T1911 arg1Of TNF,and
R1378 T1911 T1913 arg1Of and,are
R1379 T1912 T1911 arg2Of IL-1,and
R1380 T1913 T1920 arg1Of are,and
R1381 T1916 T1915 arg1Of potent,very
R1382 T1917 T1913 arg2Of activators,are
R1383 T1917 T1914 arg1Of activators,both
R1384 T1917 T1916 arg1Of activators,potent
R1385 T1917 T1918 arg1Of activators,of
R1386 T1919 T1918 arg2Of NF-κB,of
R1387 T1921 T1922 arg1Of it,can
R1388 T1921 T1923 arg1Of it,be
R1389 T1921 T1924 arg2Of it,expected
R1390 T1924 T1920 arg2Of expected,and
R1391 T1924 T1922 arg2Of expected,can
R1392 T1924 T1923 arg2Of expected,be
R1393 T1927 T1926 arg1Of activation,NF-κB
R1394 T1927 T1928 arg1Of activation,by
R1395 T1927 T1931 arg1Of activation,mediates
R1396 T1930 T1928 arg2Of cytokines,by
R1397 T1930 T1929 arg1Of cytokines,these
R1398 T1931 T1924 arg3Of mediates,expected
R1399 T1931 T1925 arg1Of mediates,that
R1400 T1932 T1931 arg2Of most,mediates
R1401 T1932 T1933 arg1Of most,of
R1402 T1936 T1933 arg2Of activities,of
R1403 T1936 T1934 arg1Of activities,their
R1404 T1936 T1935 arg1Of activities,pro-inflammatory
R1405 T1936 T1937 arg1Of activities,in
R1406 T1938 T1937 arg2Of RA,in
R1407 T1938 T1939 arg1Of RA,(
R1408 T1940 T1939 arg2Of reviewed,(
R1409 T1940 T1941 arg1Of reviewed,in
R1410 T1940 T1942 arg1Of reviewed,[
R1411 T1943 T1942 arg2Of 3,[
R1412 T1944 T1942 arg3Of ],[
R1413 T1945 T1939 arg3Of ),(

UBERON-AE

Id Subject Object Predicate Lexical cue
T1747 15-22 http://purl.obolibrary.org/obo/UBERON_0012131 denotes central

GO-BP

Id Subject Object Predicate Lexical cue
T2498 433-449 http://purl.obolibrary.org/obo/GO_0051092 denotes NF-κB activation
T2497 385-404 http://purl.obolibrary.org/obo/GO_0051092 denotes activators of NF-κB
T2496 136-150 http://purl.obolibrary.org/obo/GO_0051092 denotes activate NF-κB
T2490 41-53 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

GO-MF

Id Subject Object Predicate Lexical cue
T2517 359-363 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1
T2516 225-229 http://purl.obolibrary.org/obo/GO_0005149 denotes IL-1

sentences

Id Subject Object Predicate Lexical cue
T1757 351-544 Sentence denotes TNF and IL-1 are both very potent activators of NF-κB and it can be expected that NF-κB activation by these cytokines mediates most of their pro-inflammatory activities in RA (reviewed in [3]).
T1756 158-350 Sentence denotes It is well accepted that proinflammatory cytokines such as TNF and IL-1 play an important role, and administration of TNF antagonists is an effective treatment for severe RA (reviewed in [9]).
T1755 0-157 Sentence denotes Since NF-κB is central to the process of inflammation in RA, much research deals with the identification of the molecular triggers that activate NF-κB in RA.
T20 0-157 Sentence denotes Since NF-κB is central to the process of inflammation in RA, much research deals with the identification of the molecular triggers that activate NF-κB in RA.
T21 158-350 Sentence denotes It is well accepted that proinflammatory cytokines such as TNF and IL-1 play an important role, and administration of TNF antagonists is an effective treatment for severe RA (reviewed in [9]).
T22 351-544 Sentence denotes TNF and IL-1 are both very potent activators of NF-κB and it can be expected that NF-κB activation by these cytokines mediates most of their pro-inflammatory activities in RA (reviewed in [3]).

simple1

Id Subject Object Predicate Lexical cue
T2576 351-354 Protein denotes TNF
T2575 276-279 Protein denotes TNF
T2574 217-220 Protein denotes TNF

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T3546 351-354 Protein denotes TNF
T3545 276-279 Protein denotes TNF
T3544 217-220 Protein denotes TNF

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T3290 351-354 Protein denotes TNF
T3289 276-279 Protein denotes TNF
T3288 217-220 Protein denotes TNF

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T3694 295-331 Regulation denotes an effective treatment for severe RA
T3661 183-220 Protein denotes proinflammatory cytokines such as TNF
T3659 453-468 Protein denotes these cytokines
T3658 399-404 Protein denotes NF-κB
T3644 57-59 Protein denotes RA
T3636 351-354 Protein denotes TNF
T3630 359-363 Protein denotes IL-1
T3623 145-150 Protein denotes NF-κB
T3616 276-291 Entity denotes TNF antagonists
T3611 183-216 Protein denotes proinflammatory cytokines such as
T3605 523-525 Protein denotes RA
T3602 318-331 Protein denotes for severe RA
T3600 6-11 Protein denotes NF-κB
T3686 276-279 Protein denotes TNF
T3681 154-156 Protein denotes RA
T3675 368-404 Entity denotes both very potent activators of NF-κB
T3669 225-229 Protein denotes IL-1
T3668 433-468 Protein denotes NF-κB activation by these cytokines
R2768 T3602 T3694 themeOf for severe RA,an effective treatment for severe RA

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T3339 469-477 Positive_regulation denotes mediates
T3338 439-449 Positive_regulation denotes activation
T3337 433-438 Protein denotes NF-κB
T3336 399-404 Protein denotes NF-κB
T3335 359-363 Protein denotes IL-1
T3334 351-354 Protein denotes TNF
T3333 276-279 Protein denotes TNF
T3332 225-229 Protein denotes IL-1
T3331 217-220 Protein denotes TNF
T3330 136-144 Positive_regulation denotes activate
T3329 145-150 Protein denotes NF-κB
T3328 6-11 Protein denotes NF-κB
R2648 T3329 T3330 themeOf NF-κB,activate
R2652 T3337 T3338 themeOf NF-κB,activation
R2654 T3338 T3339 themeOf activation,mediates

test3

Id Subject Object Predicate Lexical cue
T1712 351-354 Protein denotes TNF
T1711 276-279 Protein denotes TNF
T1710 217-220 Protein denotes TNF
T1682 351-354 Protein denotes TNF
T1681 276-279 Protein denotes TNF
T1680 217-220 Protein denotes TNF